Watchlist Price Alert

scPharmaceuticals Inc. (SCPH)

NASDAQ: SCPH · Real-Time Price · USD

2.27

-0.05 (-2.16%)

At close: May 14, 2025, 3:59 PM

2.24

-1.32%

After-hours: May 14, 2025, 04:00 PM EDT

-2.16% (1D)

Bid	2.17
Market Cap	114.14M
Revenue (ttm)	36.33M
Net Income (ttm)	-85.15M
EPS (ttm)	-1.79
PE Ratio (ttm)	-1.27
Forward PE	-11.05
Analyst	Buy

Ask	2.9
Volume	577,230
Avg. Volume (20D)	449,155
Open	2.34
Previous Close	2.32
Day's Range	2.23 - 2.39
52-Week Range	1.94 - 5.65
Beta	0.16

About SCPH

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol SCPH

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SCPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

New

scPharmaceuticals has released their quartely earnings on May 14, 2025:

Revenue of $11.75M exceeds estimates by $122K, with 92.59% YoY growth.

EPS of -0.37 misses estimates by -0.09, with -2.78% YoY decline.

Why Price Moved

2 months ago

-1.89%

scPharmaceuticals shares are trading higher after ... Unlock content with Pro Subscription

5 months ago

-5.82%

ScPharmaceuticals shares are trading lower after the company disclosed observed variability during shelf-life testing in one lot of its SCP-111 combination product. This may result in the submission occurring later in 2025.

News

Just now · seekingalpha.com

scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript

scPharmaceuticals Inc. (NASDAQ:SCPH ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants William Thorpe - Investor Relations John Tucker - Chief Executive Officer Steve Pars...

17 hours ago · zacks.com

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates

ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.36 per share a year ago.

1 month ago · seekingalpha.com

scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript

scPharmaceuticals Inc. (NASDAQ:SCPH ) Q4 2024 Results Conference Call March 19, 2025 4:30 PM ET Company Participants Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve Par...

1 month ago · zacks.com

ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates

ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.35 per share a year ago.

2 months ago · zacks.com

ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy?

ScPharmaceuticals (SCPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.